Figure 6.

The effects of NSD-1015 (25 mg kg⁻¹ i.p.) or saline pretreatment on locomotor activity and disability scores induced by A-86929 (0.04 mg kg⁻¹ s.c.), quinpirole (0.1 mg kg⁻¹ i.p.), A-86929 (0.08 mg kg⁻¹ s.c.) and quinpirole (0.1 mg kg⁻¹ i.p.), and L-DOPA (5 mg kg⁻¹ s.c.) accumulated over 2 h (n=4) in MPTP-lesioned marmosets. Doses were chosen to give comparable levels of locomotor activity and disability scores. The data are expressed as mean±s.e.mean ^*P<0.05 vs saline pretreatment group.